Indefinite Delivery Contract SPE2DX15D9238

This indefinite delivery contract (IDC) was awarded by the U.S. Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The IDC has a ceiling value of $4,999,999 and runs through the end of 2025, enabling DLA to issue firm fixed-price delivery orders for a broad range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide.

The delivery orders under this IDC cover a diverse portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, including specialized pharmaceuticals such as Xolair, Nucala, Botox, Eylea, and contraceptive products. DMS Pharmaceutical Group, based in Park Ridge, Illinois, has demonstrated its capability to reliably fulfill orders for these critical pharmaceutical items on a recurring basis, without any set-aside designations. This contract allows the DLA to efficiently procure the necessary medications and supplies to meet the medical requirements of the Department of Defense healthcare system.